Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConduit Hldg Regulatory News (CRE)

Share Price Information for Conduit Hldg (CRE)

Share Price is delayed by 15 minutes
Get Live Data
445.50    0.50 (0.11%)
Bid:
430.50
Ask:
445.50
Spread: 15.00 (3.484%)
Market Cap: £658.17m
CRE Live PriceLast checked at - London Stock Exchange

Intraday Conduit Hldg Share Chart

Pre-close Trading Statement

20 Apr 2009 07:00

RNS Number : 7777Q
Creston PLC
20 April 2009
 



 20 April 2009

Creston plc 

Pre-Close Trading Statement

Creston plc (LSE: CRE), the Insight and Communications Group, provides an update on trading prior to entering its close period in advance of the preliminary results for the year ended 31 March 2009.

In the 2009 financial year, the Company has performed ahead of consensus forecasts for revenue (achieving 4% year-on-year growth), EBIT, EBITDA, earnings per share and had a lower net debt position. 

This strong performance has been driven by an excellent new business performance that more than compensates for general market softness. Since the Interim Statement in November 2008, there have been a number of significant new business wins across the Group from both existing and new clients. These wins include Astellas, Boehringer Ingelheim, E-ON, GSK, Marie Curie Cancer Care, Panasonic, Spicers and Toyota. Net new business wins for the year will generate over £15 million in revenue (2008: £9 million). The Group continues to have a healthy pipeline of new business, especially in digital and on-line research. 

All acquired Group companies have completed their earn-out periods by 31 March 2009 and the final deferred consideration, which can now be finalised and is no longer contingent upon future profit levels, will be detailed in the preliminary announcement and will be settled in December 2009 and June 2010. 

At 31 March 2009, net debt was approximately £19 million having been reduced by over £12 million since September 2008, after a strong cash generating performance during the second half of the financial year. This reduction in net debt also follows the settlement of over £13 million deferred consideration in respect of DLKW.

The Group maintained tight management of its key performance indicators covering revenue and profit per head and operating profit margin. Consequently the Group ends the year with operating costs aligned to revenues forecast for the new financial year.

Creston plc expects to announce its preliminary results for the year ended 31 March 2009 on Tuesday, 23 June 2009.

-Ends- 

  

Enquiries: 

Creston plc

www.creston.com 

Don Elgie, Chief Executive

020 7930 9757

Barrie Brien, COO/CFO

Hogarth Partnership Limited

020 7357 9477

Chris Matthews / Fiona Noblet/ 

Anthony Arthur

Investec Bank (UK) Limited 

Erik Anderson/Ben Poynter

020 7597 5145

NOTES TO EDITORS:

Publication quality photographs are available through Hogarth on the numbers shown above.

About Creston plc

Since its inception in 2001, Creston has brought 10 leading brands under one roof in the UK, offering a host of blue-chip clients a range of services spanning advertising, public relations, digital marketing, market research, direct marketing and customer relationship marketing (CRM), among many others.

Creston is divided into two divisions: Insight, which encompasses those agencies engaged in understanding consumer behaviour, attitudes and needs, via research and evaluation; and Communications, which comprises agencies involved in influencing, shaping and changing consumer behaviours, attitudes and needs - this includes PR, advertising and marketing. Both divisions are entirely complementary.

Creston's share price is quoted on the London Stock Exchange under the symbol CRE and is published in the Financial Times, The Daily Telegraph, The Times and the London Evening Standard.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTGUUAPCUPBGCM
Date   Source Headline
8th Dec 20233:45 pmRNSPurchase of Shares by Employee Benefit Trust
7th Dec 20232:22 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20232:52 pmRNSPurchase of Shares by Employee Benefit Trust
6th Dec 20237:00 amRNSPurchase of Shares by Employee Benefit Trust
5th Dec 20233:46 pmRNSPurchase of Shares by Employee Benefit Trust
1st Dec 20235:28 pmRNSPurchase of Shares by Employee Benefit Trust
30th Nov 20233:28 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20233:51 pmRNSPurchase of Shares by Employee Benefit Trust
29th Nov 20237:00 amRNSHolding(s) in Company
28th Nov 20234:41 pmRNSPurchase of Shares by Employee Benefit Trust
27th Nov 20233:17 pmRNSPurchase of Shares by Employee Benefit Trust
24th Nov 20232:02 pmRNSPurchase of Shares by Employee Benefit Trust
23rd Nov 20234:25 pmRNSPurchase of Shares by Employee Benefit Trust
22nd Nov 20235:06 pmRNSPurchase of Shares by Employee Benefit Trust
17th Nov 20234:20 pmRNSPurchase of Shares by Employee Benefit Trust
8th Nov 20237:00 amRNSDirectorate Change
8th Nov 20237:00 amRNSThird Quarter 2023 Trading Update
26th Oct 20237:00 amRNSNotice of Q3 2023 Trading Update and Webcast
25th Sep 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
18th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
15th Aug 20237:00 amRNSDirector/PDMR Shareholding
1st Aug 20233:59 pmRNSDirector/PDMR Shareholding
28th Jul 20237:00 amRNSDirector/PDMR Shareholding
27th Jul 20235:20 pmRNSHolding(s) in Company
26th Jul 20237:00 amRNSConduit Interim Results 2023
25th Jul 20237:00 amRNSDirectorate Change
14th Jul 20232:55 pmRNSNotice of H1 2023 Results and Conference Call
22nd Jun 20237:00 amRNSNotice of IFRS 17 Briefing Call
15th Jun 20234:48 pmRNSHolding(s) in Company
13th Jun 20237:00 amRNSDirector/PDMR Shareholding
23rd May 20237:00 amRNSTransfer of Treasury Shares
19th May 20234:56 pmRNSDirector/PDMR Shareholding
19th May 20237:00 amRNSDirector/PDMR Shareholding
18th May 20237:00 amRNSResults of 2023 AGM
17th May 20237:00 amRNSFirst Quarter 2023 Trading Update
4th May 20234:20 pmRNSNotice of Q1 2023 Trading Update and Webcast
17th Apr 20232:09 pmRNSNotice of AGM
6th Apr 20232:50 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 20237:00 amRNSDirector/PDMR Shareholding
22nd Mar 20237:00 amRNSHolding(s) in Company
7th Mar 20234:28 pmRNSDirector/PDMR Shareholding
6th Mar 202311:25 amRNSPublication of 2022 Annual Report and Accounts
22nd Feb 20237:00 amRNSYear ended 31 December 2022 Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.